NICOLETTI, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 8.484
EU - Europa 4.702
AS - Asia 2.252
AF - Africa 508
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 10
Totale 15.989
Nazione #
US - Stati Uniti d'America 8.058
IE - Irlanda 1.378
UA - Ucraina 1.245
CN - Cina 1.148
IT - Italia 921
SG - Singapore 902
CA - Canada 410
RU - Federazione Russa 335
CI - Costa d'Avorio 302
DE - Germania 267
SE - Svezia 221
SN - Senegal 180
GB - Regno Unito 60
FR - Francia 52
VN - Vietnam 50
IN - India 49
CH - Svizzera 36
IR - Iran 31
AT - Austria 29
NL - Olanda 27
UZ - Uzbekistan 26
BE - Belgio 23
BG - Bulgaria 23
PL - Polonia 23
NG - Nigeria 18
EU - Europa 15
GR - Grecia 15
AU - Australia 14
MX - Messico 14
FI - Finlandia 9
JP - Giappone 9
LB - Libano 9
RO - Romania 9
BR - Brasile 7
HK - Hong Kong 7
TR - Turchia 6
HU - Ungheria 5
NZ - Nuova Zelanda 4
PT - Portogallo 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
GE - Georgia 3
MK - Macedonia 3
BA - Bosnia-Erzegovina 2
EG - Egitto 2
KR - Corea 2
LI - Liechtenstein 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BD - Bangladesh 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
ES - Italia 1
GH - Ghana 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 15.989
Città #
Jacksonville 1.484
Dublin 1.376
Chandler 1.331
Boardman 656
Singapore 611
Chicago 494
Lawrence 382
Cambridge 379
Andover 373
Nanjing 368
Toronto 329
Abidjan 302
Houston 297
Catania 282
Ashburn 227
Des Moines 227
San Mateo 198
Dakar 180
Wilmington 148
Nanchang 129
Grafing 127
Hebei 98
Saint Petersburg 93
Jiaxing 81
Ottawa 79
Shenyang 77
Santa Clara 69
Tianjin 62
Changsha 60
Bremen 46
Dong Ket 46
Moscow 38
Los Angeles 36
Falls Church 33
Norwalk 28
Beijing 27
Seattle 26
Hangzhou 25
Milan 25
Brussels 23
Messina 23
Washington 23
Jinan 22
Pune 22
Vercelli 20
Guangzhou 19
Kunming 19
Abuja 18
Dearborn 18
Acireale 17
Ardabil 17
Den Haag 17
Palermo 17
Tappahannock 17
Leawood 16
Ningbo 16
Augusta 15
Liberty Lake 15
San Francisco 14
Ann Arbor 12
Monmouth Junction 12
Mountain View 12
Rome 12
Florence 11
Frankfurt Am Main 11
Licata 11
Mascalucia 11
Ragusa 11
Zhengzhou 11
Amsterdam 10
Chiaramonte Gulfi 10
Maletto 10
Redwood City 10
Vienna 10
Lausanne 9
Melbourne 9
Mumbai 9
Vicenza 9
Hanover 8
Padova 8
Puerto Juárez 8
Santa Teresa Di Riva 8
Changchun 7
Edinburgh 7
Motta Sant'Anastasia 7
Assago 6
Civitavecchia 6
Munich 6
Naples 6
Paris 6
Redmond 6
Budapest 5
Hefei 5
Helsinki 5
Ludwigshafen 5
Milazzo 5
New York 5
Reggio Calabria 5
San Giovanni la Punta 5
Tokyo 5
Totale 11.551
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 285
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 184
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 125
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 101
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10 77
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 76
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 75
CD3+CD25+ cells, CD3+CD4+/CD3+CD8+ ratio, HLA alloantigen association and ICA in type 1 (insulin-dependent) diabetes 74
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 72
Ageing: from inflammation to cancer. 71
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 70
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 70
CORRELATION BETWEEN ISLET CELL ANTIBODIES AND ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES IN HEALTHY 1ST-DEGREE RELATIVES OF TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS 70
β-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: Correlation with the MAP kinase pathway 70
Akt as a therapeutic target in cancer 69
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 68
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 66
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 65
Advances in targeting signal transduction pathways. 63
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 62
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 62
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 61
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 61
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 61
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome 60
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 60
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 59
Vitamin D3: a helpful immuno-modulator 59
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 59
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 59
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 59
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 59
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 59
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 59
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 58
Emerging therapeutic targets for the treatment of hepatic fibrosis 58
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 58
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 58
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 58
Emerging MEK inhibitors 58
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo 57
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 57
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 56
Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease 56
Use of uk114 in the treatment of leishmaniasis 56
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 56
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 56
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat 55
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 55
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 55
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 55
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 54
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 54
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 54
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 54
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells 54
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 54
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients 54
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 54
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 54
Epilepsy and multiple sclerosis 53
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death 53
EFFECTS OF OCTREOTIDE ON THE GLYCEMIC LEVELS IN INSULIN-DEPENDENT DIABETIC-PATIENTS - COMPARATIVE-STUDY BETWEEN ADMINISTRATION THROUGH MULTIPLE SUBCUTANEOUS INJECTIONS AND CONTINUOUS SUBCUTANEOUS INFUSION 53
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 53
Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells 53
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 53
Emerging Raf inhibitors 52
An imidazoline compound completely counteracts interleukin-1 [beta] toxic effects to rat pancreatic islet [beta] cells 52
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 52
Induction of caspase - independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO 52
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 52
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 52
Characterization of the pathophysiological role of CD47 in uveal melanoma 52
Effects of Tumour Necrosis Factor-alpha on Human Sperm Motility and Apoptosis 51
Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoiimune diabetes in male NOD mice 51
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 51
INCREASED RATE OF SURVIAL IN STREPTOCOCCUS PNEUMONIAE - INFECTED RATS TREATED WITH THE NEW IMMUNODULAR PITODIMOD 51
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 51
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 51
The effect of omega-3 fatty acids on capsular tissue around the breast implants 51
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 50
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia 50
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease 50
The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir 50
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration 50
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 50
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 50
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 50
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 50
ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES, ISLET CELL ANTIBODIES AND GAMMA-INTERFERON SERUM LEVELS IN NEWLY DIAGNOSED IDDM PATIENTS 50
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 50
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 50
Sodium fucidate (fusidin) ameliorates the course of monophasic experimantal allergic encephalomyelitis in the Lewis rat 49
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance 49
FK-506 PREVENTS DIABETES IN DIABETES-PRONE BB WOR RATS 49
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 49
Modulation of heat shock proteins during macrophage differentiation. 49
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide 49
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 49
mTOR as a multifunctional therapeutic target in HIV infection 48
Totale 6.128
Categoria #
all - tutte 60.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.527 0 0 249 139 241 36 266 6 183 24 264 119
2020/20212.381 25 196 300 25 586 55 299 11 309 15 429 131
2021/20222.830 329 384 4 56 439 57 401 93 253 8 72 734
2022/20234.387 411 153 55 375 428 804 19 775 1.069 60 130 108
2023/20241.789 120 249 87 170 65 392 12 122 10 75 282 205
2024/20251.615 65 1.094 456 0 0 0 0 0 0 0 0 0
Totale 16.529